Herbert Wiesinger

1.3k total citations
51 papers, 953 citations indexed

About

Herbert Wiesinger is a scholar working on Ophthalmology, Molecular Biology and Physiology. According to data from OpenAlex, Herbert Wiesinger has authored 51 papers receiving a total of 953 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Ophthalmology, 13 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Herbert Wiesinger's work include Glaucoma and retinal disorders (6 papers), Adipose Tissue and Metabolism (6 papers) and Vitamin D Research Studies (3 papers). Herbert Wiesinger is often cited by papers focused on Glaucoma and retinal disorders (6 papers), Adipose Tissue and Metabolism (6 papers) and Vitamin D Research Studies (3 papers). Herbert Wiesinger collaborates with scholars based in Germany, United States and United Kingdom. Herbert Wiesinger's co-authors include Gerhard Heldmaier, DuPont Guerry, Martin Klingenspor, Thomas Ruf, Stephan Steinlechner, David G. Nicholls, Sonia Cunningham, Astrid Buchberger, Ray Williams and Susanne Klaus and has published in prestigious journals such as Biochemical Journal, Journal of Nutrition and British Journal of Cancer.

In The Last Decade

Herbert Wiesinger

45 papers receiving 851 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Herbert Wiesinger Germany 19 319 223 146 130 128 51 953
Theodor Heinrich Schiebler Germany 21 195 0.6× 546 2.4× 13 0.1× 100 0.8× 28 0.2× 42 1.5k
T. H. Schiebler Germany 17 151 0.5× 427 1.9× 10 0.1× 61 0.5× 24 0.2× 37 1.1k
D. Renz Germany 12 127 0.4× 392 1.8× 91 0.6× 21 0.2× 6 0.0× 18 1.1k
H. D. PURVES New Zealand 17 122 0.4× 145 0.7× 14 0.1× 48 0.4× 22 0.2× 46 995
Frances E. Carr United States 23 94 0.3× 574 2.6× 31 0.2× 31 0.2× 10 0.1× 60 1.6k
Gracious R. Ross United States 19 179 0.6× 379 1.7× 13 0.1× 91 0.7× 11 0.1× 49 1.0k
Roy H. Maffly United States 13 129 0.4× 344 1.5× 11 0.1× 57 0.4× 13 0.1× 23 726
R Mornex France 22 363 1.1× 226 1.0× 13 0.1× 35 0.3× 5 0.0× 107 1.2k
Ewald Wöll Austria 18 102 0.3× 543 2.4× 73 0.5× 15 0.1× 5 0.0× 33 841

Countries citing papers authored by Herbert Wiesinger

Since Specialization
Citations

This map shows the geographic impact of Herbert Wiesinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert Wiesinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert Wiesinger more than expected).

Fields of papers citing papers by Herbert Wiesinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert Wiesinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert Wiesinger. The network helps show where Herbert Wiesinger may publish in the future.

Co-authorship network of co-authors of Herbert Wiesinger

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert Wiesinger. A scholar is included among the top collaborators of Herbert Wiesinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert Wiesinger. Herbert Wiesinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ploeger, Bart A., Andrea Wagenfeld, Herbert Wiesinger, et al.. (2025). Zabedosertib, a novel interleukin-1 receptor-associated kinase-4 inhibitor, shows a favorable pharmacokinetic and safety profile across multiple phase 1 studies. Frontiers in Pharmacology. 16. 1521505–1521505.
2.
Wiesinger, Herbert, Frank Richard, Dietmar Trummer, et al.. (2012). Bioequivalence Evaluation of a Folate-Supplemented Oral Contraceptive Containing Ethinylestradiol/Drospirenone/Levomefolate Calcium versus Ethinylestradiol/Drospirenone and Levomefolate Calcium Alone. Clinical Drug Investigation. 32(10). 673–684. 3 indexed citations
3.
Stupp, Roger, A. Tosoni, Jacoline E. C. Bromberg, et al.. (2011). Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group. Annals of Oncology. 22(9). 2144–2149. 31 indexed citations
4.
Vandemeulebroecke, Marc, et al.. (2009). Assessment of QTc‐prolonging potential of BX471 in healthy volunteers. A ‘thorough QTc study’ following ICH E14 using various QT correction methods. British Journal of Clinical Pharmacology. 68(3). 435–446. 12 indexed citations
5.
Scott, Edwina N., Anne Thomas, L Rhoda Molife, et al.. (2009). A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI™), in patients with advanced solid tumours. Cancer Chemotherapy and Pharmacology. 64(2). 425–429. 32 indexed citations
6.
Arnold, Dirk, Wieland Voigt, Philipp Kiewe, et al.. (2009). Weekly administration of sagopilone (ZK-EPO), a fully synthetic epothilone, in patients with refractory solid tumours: results of a phase I trial. British Journal of Cancer. 101(8). 1241–1247. 23 indexed citations
7.
Schmid, Peter, Philipp Kiewe, K. Possinger, et al.. (2009). Phase I study of the novel, fully synthetic epothilone sagopilone (ZK-EPO) in patients with solid tumors. Annals of Oncology. 21(3). 633–639. 30 indexed citations
8.
9.
Steinmeyer, Andreas, et al.. (2001). Synthesis and biological activities of a new series of secosteroids: vitamin D phosphonate hybrids. Steroids. 66(3-5). 257–266. 14 indexed citations
10.
Shankar, V., Valarie Byford, David E. Prosser, et al.. (2001). Metabolism of a 20-methyl substituted series of vitamin D analogs by cultured human cells: apparent reduction of 23-hydroxylation of the side chain by the 20-methyl group. Biochemical Pharmacology. 61(7). 893–902. 6 indexed citations
11.
Danielsson, Carina, Sepideh Nayeri, Herbert Wiesinger, Ruth Thieroff‐Ekerdt, & Carsten Carlberg. (1996). Potent gene regulatory and antiproliferative activities of 20-methyl analogues of 1,25 dihydroxyvitamin D3. Journal of Cellular Biochemistry. 63(2). 199–206. 17 indexed citations
12.
Wiesinger, Herbert, Susanne Klaus, Gerhard Heldmaier, O. Champigny, & Daniel Ricquier. (1990). Increased nonshivering thermogenesis, brown fat cytochrome-c oxidase activity, GDP binding, and uncoupling protein mRNA levels after short daily cold exposure of Phodopus sungorus. Canadian Journal of Physiology and Pharmacology. 68(2). 195–200. 34 indexed citations
13.
14.
Bichler, A., Herbert Wiesinger, & Manuel Mayr. (1978). Spezifische Glucocorticoidrezeptoraktivität in den Lungen und Corticosteroidgehalt im Plasma neugeborener Kaninchen in den ersten Lebensstunden. Archives of Gynecology and Obstetrics. 226(4). 307–313. 1 indexed citations
15.
Wiesinger, Herbert. (1972). The Effect of Electrical Curren on the Crystalline Lens. VCU Scholars Compass (Virginia Commonwealth University). 8(4). 254–258. 1 indexed citations
16.
Wiesinger, Herbert. (1964). Ocular Findings In Mentally Retarded Children. Journal of Pediatric Ophthalmology & Strabismus. 1(3). 37–41. 4 indexed citations
17.
Wiesinger, Herbert, DuPont Guerry, & Walter J. Geeraets. (1960). Recent Experiences with Light Coagulation. Archives of Ophthalmology. 64(2). 254–259. 7 indexed citations
18.
Guerry, DuPont & Herbert Wiesinger. (1960). Amyloid Disease of Conjunctiva and Tarsus. American Journal of Ophthalmology. 49(6). 1413–1415. 16 indexed citations
19.
Guerry, DuPont & Herbert Wiesinger. (1957). Spontaneous Cyst of the Iris Stroma. American Journal of Ophthalmology. 44(1). 106–107. 18 indexed citations
20.
Wiesinger, Herbert, Hans Kaunitz, & Charles A. Slanetz. (1955). Hornhautveränderungen bei Ratten im Riboflavinmangel. Ophthalmologica. 129(6). 389–395. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Theodor Heinrich Schiebler Breakdown of academic impact, for papers by T. H. Schiebler Breakdown of academic impact, for papers by D. Renz Breakdown of academic impact, for papers by H. D. PURVES Breakdown of academic impact, for papers by Frances E. Carr Breakdown of academic impact, for papers by Gracious R. Ross Breakdown of academic impact, for papers by Roy H. Maffly Breakdown of academic impact, for papers by R Mornex Breakdown of academic impact, for papers by Ewald Wöll
Rankless by CCL
2026